Cabilinga, Zamsodyn C.
HRN: 18-95-96 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2026
CEFUROXIME 750MG (VIAL)
07/19/2026
07/26/2026
IV
750 Mg
Q 8
T/C PCAP
Checking Final Appropriateness